USPTO serial 79176495
PATHOMICS
Reviewed by CopyMark Law Group
Reg. 4962140Status 707Renewal
- Filing date
- Status date
- Registration date
- May 24, 2016
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PATHOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B. Street, Suite 2200San Diego, CA 92101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical and medical compositions for human and/or veterinary use, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostic preparations for medical purposes; in-vivo diagnostic preparations for medical purposes ] | SECTION 71 - CANCELLED | — |
| 035 | Investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; business statistical information all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, namely, database management services that allow for information storage in the fields of diagnostic testing and results, database management of medical, hospital, insurance and billing records and information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information in the fields of medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records | ACTIVE | — |
| 042 | Medical research services; conducting clinical trials for others; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services, namely, clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Retroscreen Virology Limited
- Other trademarks owned by Retroscreen Virology Limited
- Other trademarks owned by HVIVO SERVICES LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named PATHOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 12, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 16, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 8, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 8, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jul 7, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 7, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 7, 2022 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Oct 31, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| May 24, 2022 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| May 23, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 11, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 24, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 9, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 24, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 16, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 8, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 17, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 17, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 17, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 26, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jan 12, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 31, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 4, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 2, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 1, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 21, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |